Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,817,308
-
Total 13F shares
-
1,816,116
-
Share change
-
+100,043
-
Total reported value
-
$3,018,833
-
Price per share
-
$1.53
-
Number of holders
-
10
-
Value change
-
+$157,533
-
Number of buys
-
7
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q4 2025
As of 31 Dec 2025,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,816,116 shares.
The largest 10 holders included
VANGUARD GROUP INC, Centric Wealth Management, RITHOLTZ WEALTH MANAGEMENT, Centerpoint Advisory Group, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Cambridge Investment Research Advisors, Inc., Daytona Street Capital LLC, UBS Group AG, SRH ADVISORS, LLC, and TUCKER ASSET MANAGEMENT LLC.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.